MedTrace Logo

Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women

NCT00380146 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2016-10-26

No results posted yet for this study

Summary

The main purpose of this study is to compare the drug levels of sulfadoxine-pyrimethamine found when given to pregnant women for the prevention of malaria to those found in pregnant women given the same drug with artesunate for the treatment of malaria, and also with those drug levels found in non-pregnant women in other malaria treatment studies.

Conditions

Interventions

DRUG

sulfadoxine-pyrimethamine

Sponsors & Collaborators

  • Global Fund

    collaborator OTHER

  • Medical Research Council, South Africa

    collaborator OTHER

  • Professor Karen I Barnes

    lead OTHER

Principal Investigators

  • Karen I Barnes, MBChB · University of Cape Town

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-02-29
Completion
2008-03-31

Countries

  • Mozambique

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380146 on ClinicalTrials.gov